Search
for
Sort by
Research 301–330 of 975
- General Dermatology
- Westwood Carolina Conference on Clinical Dermatology
- Mutational spectrum in 101 patients with hypohidrotic ectodermal dysplasia and breakpoint mapping in independent cases of rare genomic rearrangements
- Pharmacology of anabolic steroids
- Is dehydroepiandrosterone a hormone?
- Recent advances in electrospun nanofibers for wound healing
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Dermatoses of pregnancy
- Vitamin D and the skin: Focus on a complex relationship: A review
- Cutaneous manifestations of systemic lupus erythematosus
- Epithelial Skin Biology
- Biology of the wool follicle: an excursion into a unique tissue interaction system waiting to be re‐discovered
- Delivery and targeting of nanoparticles into hair follicles
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Central hair loss in African American women: Incidence and potential risk factors
- Niosomes as a propitious carrier for topical drug delivery
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Alopecia areata: An update
- β-Catenin Signaling Increases in Proliferating NG2+ Progenitors and Astrocytes during Post-Traumatic Gliogenesis in the Adult Brain
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- The Majority of Multipotent Epidermal Stem Cells Do Not Protect Their Genome by Asymmetrical Chromosome Segregation
- Stem cell markers (cytokeratin 15, CD34 and nestin) in primary scarring and nonscarring alopecia
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Alopecia With Endocrine Therapies in Patients With Cancer
- Wnt signaling: the good and the bad
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Emerging treatments in alopecia
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Roles of tumor suppressors in regulating tumor-associated inflammation